# Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

> **NCT04917042** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 10 (actual)

## Conditions studied

- Peripheral Nerve Sheath Tumor

## Interventions

- **DRUG:** Tazemetostat

## Key facts

- **NCT ID:** NCT04917042
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-25
- **Primary completion:** 2025-02-14
- **Final completion:** 2026-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04917042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04917042, "Tazemetostat in Malignant Peripheral Nerve Sheath Tumors". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04917042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*